Hoosier State Today

Indiana hospitals are actively managing a national shortage of intravenous (IV) fluids, affecting healthcare providers across the United States. Due to delays in shipments from third-party vendors, hospitals are reassessing their stock levels and prioritizing supplies for critically ill patients.

"Despite Baxter’s return to 60% production, and the incoming shipments from international suppliers, it could take weeks until some hospitals begin receiving their allocation of IV fluids," said Blake Dye, interim president of the Indiana Hospital Association (IHA).

To cope with the shortage, hospitals have put conservation plans in place. These plans involve optimizing fluid use for each patient, considering alternative therapies, and reserving supplies for critical care. As part of these efforts, some elective and non-emergent procedures are being rescheduled.

"We’re certainly not alone in this predicament as this is a nationwide shortage impacting every state," Dye added. "Hoosiers should feel confident that Indiana’s hospitals are managing through the current situation, taking proactive measures that are aligned with clinical best practices, and are working diligently to minimize the impact on patient care."

Emergency care and urgent surgeries continue without interruption. The IHA is coordinating closely with its 174 member hospitals, the Indiana Department of Health (IDOH), and the American Hospital Association to monitor supply levels and address the nationwide disruption.

State Health Commissioner Lindsay M. Weaver stated, "We appreciate the way that Indiana hospitals are minimizing the impact this national shortage is having on patient care. The Indiana Department of Health is in contact with Indiana hospitals and remains dedicated to working with our state and federal partners until the situation is resolved."